Clarification comes on cannabis scheduling in the Medicines Act
Kudos to the health department for clarifying this at such a time, as cannabis can become an SA industry with exponential growth potential
On May 23 2019, the minister of health published a notice in the Government Gazette that excluded certain preparations containing cannabidiol (CBD) from the operation of certain provisions of the Medicines and Related Substances Act, No 101 of 1965 (Medicines Act).
This exemption provided that CBD-containing products could be sold in the market without full registration as a medicine if it contains a maximum dose of 20mg of CBD, with an accepted low risk claim, or health claim only referring to things such as general health enhancement, without any reference to specific diseases, health maintenance or relief of minor symptoms not related to a disease or disorder...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.